<html>
<head>PUBMED IDs for VHL1</head>
<body bgcolor='#C5F0F2'><h1>VHL1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9751722/'>pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation.</a> September 30  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10102622/'>Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity.</a> April 2  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10857749/'>Comparative sequence analysis of the VHL tumor suppressor gene.</a> June 17  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/16847331/'>Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3.</a> July 19  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/26035699/'>The von Hippel-Lindau tumour suppressor gene: uncovering the expression of the pVHL172 isoform.</a> October 1  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26211615/'>Isoform-specific interactions of the von Hippel-Lindau tumor suppressor protein.</a> July 2  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/28620133/'>The pVHL172 isoform is not a tumor suppressor and up-regulates a subset of pro-tumorigenic genes including TGFB1 and MMP13.</a> June 18  2017<br></body></html>
